Annual Shareholders Equity
$438.44 M
-$403.00 K-0.09%
December 31, 2024
Summary
- As of March 12, 2025, KNSA annual stockholders equity is $438.44 million, with the most recent change of -$403.00 thousand (-0.09%) on December 31, 2024.
- During the last 3 years, KNSA annual shareholders equity has risen by +$253.40 million (+136.95%).
- KNSA annual shareholders equity is now -0.09% below its all-time high of $438.84 million, reached on December 31, 2023.
Performance
KNSA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$438.44 M
+$1.43 M+0.33%
December 31, 2024
Summary
- As of March 12, 2025, KNSA quarterly stockholders equity is $438.44 million, with the most recent change of +$1.43 million (+0.33%) on December 31, 2024.
- Over the past year, KNSA quarterly shareholders equity has stayed the same.
- KNSA quarterly shareholders equity is now -0.09% below its all-time high of $438.84 million, reached on December 31, 2023.
Performance
KNSA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KNSA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.1% | 0.0% |
| 3 y3 years | +136.9% | +136.9% |
| 5 y5 years | +94.5% | +94.5% |
KNSA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +136.9% | -0.1% | +185.6% |
| 5 y | 5-year | -0.1% | +136.9% | -0.1% | +185.6% |
| alltime | all time | -0.1% | +588.7% | -0.1% | +588.7% |
Kiniksa Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $438.44 M(-0.1%) | $438.44 M(+0.3%) |
| Sep 2024 | - | $437.01 M(+0.4%) |
| Jun 2024 | - | $435.10 M(+0.7%) |
| Mar 2024 | - | $431.89 M(-1.6%) |
| Dec 2023 | $438.84 M(+10.8%) | $438.84 M(+8.3%) |
| Sep 2023 | - | $405.13 M(-1.6%) |
| Jun 2023 | - | $411.66 M(+5.5%) |
| Mar 2023 | - | $390.10 M(-1.5%) |
| Dec 2022 | $396.15 M(+114.1%) | $396.15 M(+3.2%) |
| Sep 2022 | - | $384.01 M(+150.2%) |
| Jun 2022 | - | $153.49 M(-7.7%) |
| Mar 2022 | - | $166.24 M(-10.2%) |
| Dec 2021 | $185.04 M | $185.04 M(-13.6%) |
| Sep 2021 | - | $214.05 M(-9.2%) |
| Jun 2021 | - | $235.78 M(-12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $270.70 M(-13.2%) |
| Dec 2020 | $311.94 M(+38.4%) | $311.94 M(-13.0%) |
| Sep 2020 | - | $358.51 M(+43.2%) |
| Jun 2020 | - | $250.42 M(+21.7%) |
| Mar 2020 | - | $205.83 M(-8.7%) |
| Dec 2019 | $225.42 M(-19.3%) | $225.42 M(-10.5%) |
| Sep 2019 | - | $251.91 M(-8.5%) |
| Jun 2019 | - | $275.20 M(-10.2%) |
| Mar 2019 | - | $306.52 M(+9.8%) |
| Dec 2018 | $279.27 M(-411.3%) | $279.27 M(-12.4%) |
| Sep 2018 | - | $318.91 M(-6.7%) |
| Jun 2018 | - | $341.80 M(+66.3%) |
| Mar 2018 | - | $205.48 M(-329.1%) |
| Dec 2017 | -$89.71 M(+248.6%) | -$89.71 M |
| Dec 2016 | -$25.73 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Kiniksa Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of KNSA is $438.44 M
What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual stockholders equity is $438.84 M
What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, KNSA annual stockholders equity has changed by -$403.00 K (-0.09%)
What is Kiniksa Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of KNSA is $438.44 M
What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly stockholders equity is $438.84 M
What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, KNSA quarterly stockholders equity has changed by $0.00 (0.00%)